Thin Versus Thicker Strut Thickness Stents in Primary Percutaneous Intervention

1. To evaluate clinical safety of the device in terms of Deaths, any stroke and Myocardial Infarction up to 1 year in both study groups to prove non inferiority of biomime stent 2. To evaluate presence of Target lesion and target vessel revascularization in in both study groups prove non inferiority of biomime stent 3. To evaluate target vessel non-target lesion revasularization in both study groups prove non inferiority of biomime stent